Publication | Open Access

Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial

Breast OncologyOncologyEarly Breast CancerMedicineClinical TrialsBreast CancerCancer TreatmentMaf AmplificationPharmacologyAdjuvant Zoledronic Acid